Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating combination chemotherapy for advanced urothelial cancer with decreased kidney function has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Cancer of the Renal Pelvis and Ureter
• Urethral Cancer

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED